ArticleEye (London, England)2020
Coronavirus disease 2019 presenting with conjunctivitis as the first symptom.
Article in Eye (London, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Ophthalmology-focused publications and findings on COVID-19: A systematic review.European journal of ophthalmology · 2021Pooled it
- Clinical and Prodromal Ocular Symptoms in Coronavirus Disease: A Systematic Review and Meta-Analysis.Investigative ophthalmology & visual science · 2020Pooled it
- Management of COVID-19 in Ophthalmology.Advances in experimental medicine and biology · 2024Review
- The occurrence of acute primary angle closure triggered, aggravated, and accelerated by COVID-19 infection: retrospective observational study.Frontiers in public health · 2023Observational
- Validated HPLC-PDA methodology utilized for simultaneous determination of Etoricoxib and Paracetamol in the presence of Paracetamol toxic impurities.BMC chemistry · 2022Article
- COVID-19 and cognitive impairment: neuroinvasive and blood‒brain barrier dysfunction.Journal of neuroinflammation · 2022Review
- Conjunctivitis as a sign of persistent SARS-COV-2 infection? An observational study and report of late symptoms.European journal of ophthalmology · 2021Article
- COVID-19 case presented initially with keratoconjunctivitis: A case report.Annals of medicine and surgery (2012) · 2021Article
- A comprehensive review on clinical and mechanistic pathophysiological aspects of COVID-19 Malady: How far have we come?Virology journal · 2021Review
- Focused Review: Potential Rare and Atypical Symptoms as Indicator for Targeted COVID-19 Screening.Medicina (Kaunas, Lithuania) · 2021Review
- Evidence of SARS-CoV-2 Transmission Through the Ocular Route.Clinical ophthalmology (Auckland, N.Z.) · 2021Review
- COVID-19 and the eye.Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists) · 2020Article
- Are eyes the windows to COVID-19? Systematic review and meta-analysis.BMJ open ophthalmology · 2020Article
- Human coronaviruses: ophthalmic manifestations.BMJ open ophthalmology · 2020Review
- Does the novel coronavirus use the ocular surface as an entrance into the body or as an infection site?Arquivos brasileiros de oftalmologiaArticle
Corrections and comments
- Comment on
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.